What We're Reading: Gottlieb Discusses Drug Pricing; VA Chief Might Be Replaced; Opioid Data Hard to Use
FDA Commissioner Scott Gottlieb, MD discussed the agency's role in tackling drug prices in an interview; President Trump is considering firing the head of the VA; measuring the extent of the opioid crisis with available data is more difficult than it seems.
Gottlieb Discusses FDA Role in Combatting High Drug Prices
Trump May Replace Shulkin at VA With Perry From Energy
Using Available Data to Tally Opioid Crisis More Difficult Than Expected
FDA Commissioner Scott Gottlieb, MD, is the public face of the Trump administration’s effort to lower the cost of prescription drugs. In
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025